TCL Archive Cancer Control Contract Negotiations To Start Soon; Two Weaknesses Occur In Many Proposals March 7, 1975
TCL Archive FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity. September 29, 2000
TCL Archive Special Report: KRAS Finding Changes Oncology Practice But Poses Profound Regulatory Dilemma January 30, 2009
TCL Archive Full Funding Of Indirect Costs, Other Mandates By Congress Chew Up Most Of NCI’s Extra Money December 2, 1983
